Trial · NCT07894042
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in sleep quality | Baseline (week 0) and week 8 | Change from baseline in the Pittsburgh Sleep Quality Index global score. Range 0 to 21; higher scores indicate poorer sleep quality. |
| Secondary | Insomnia severity | Weeks 0 and 8 | Insomnia Severity Index total score. Range 0 to 28; higher scores indicate more severe insomnia. |
| Secondary | Depression | Weeks 0 and 8 | Depression subscale of the 21-item Depression Anxiety Stress Scales, multiplied by 2. Range 0 to 42; higher scores indicate more depression. |
| Secondary | Anxiety | Weeks 0 and 8 | Anxiety subscale of the 21-item Depression Anxiety Stress Scales, multiplied by 2. Range 0 to 42; higher scores indicate more anxiety. |
| Secondary | Stress | Weeks 0 and 8 | Stress subscale of the 21-item Depression Anxiety Stress Scales, multiplied by 2. Range 0 to 42; higher scores indicate more stress. |
| Secondary | Fatigue | Weeks 0 and 8 | FACIT-Fatigue subscale score. Range 0 to 52; higher scores indicate less fatigue. |
| Secondary | Adherence to antiretroviral therapy | Weeks 0 and 8 | Three-item self-report adherence scale for the past 30 days. Range 0 to 100; higher scores indicate better adherence. |
| Secondary | Perceived usefulness of the mentor | Weeks 0 and 8 | Mean score of study-specific Technology Acceptance Model items on perceived usefulness, developed and validated in Cycle 1; higher scores indicate greater perceived usefulness. |
| Secondary | Perceived ease of use of the mentor | Weeks 0 and 8 | Mean score of study-specific Technology Acceptance Model items on perceived ease of use, developed and validated in Cycle 1; higher scores indicate greater ease of use. |
| Secondary | Health beliefs about sleep | Weeks 0 and 8 | Mean score of study-specific Health Belief Model items on sleep, developed and validated in Cycle 1; higher scores indicate stronger beliefs supporting healthy sleep behaviour. |
| Secondary | Usability of the mentor | Week 4 (Cycle 2) and week 8 (Cycle 3) | System Usability Scale total score. Range 0 to 100; higher scores indicate better usability. |
| Secondary | Engagement with the mentor | Weeks 1 to 4 | Number of days with a completed daily check-in, from app usage logs. |
| Secondary | Recruitment rate | 3 months from the start of Cycle 3 recruitment | Number of participants enrolled in Cycle 3, expressed as a percentage of the target sample of 70. |
| Secondary | Retention to follow-up | Week 8 | Percentage of enrolled Cycle 3 participants who complete the week 8 assessment. |
| Secondary | Attendance at nurse monitoring sessions | Weeks 2 and 4 | Percentage of participants who attend at least 1 of the 2 nurse monitoring sessions. |
| Secondary | Number of participants with adverse events | Weeks 0 to 8 | Number of participants with at least one adverse event, including events possibly related to the mentor. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07894042/registered